Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain
The use of recombinant factor VIIa in liver diseases
Heparin/heparan sulfate anticoagulant glycosaminoglycans in human plasma of healthy donors: preliminary study on a small group of recruits
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis
Overfatness, stunting and physical inactivity are determinants of plasminogen activator inhibitor-1activity, fibrinogen and thrombin–antithrombin complex in African adolescents
Activity of recombinant factor VIIa under different conditions in vitro: effect of temperature, pH, and haemodilution
High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study
Factor 8 (F8) gene mutation profile of Turkish hemophilia A patients with inhibitors
Pediatric patients with congenital heart disease: thrombin generation measured by calibrated automated thrombography
Alpha 2A adrenergic receptor polymorphism is associated with plasma von Willebrand factor levels in a general population
What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?
Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis
Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased platelet activation?
Association of platelet-derived growth factor-D gene polymorphism with ischemic stroke in a Chinese case–control study
Targeting the urine and plasma determinants of thromboxane A2 metabolism in detection of aspirin effectiveness
Factor IX gene haplotypes and its relevance for the indirect genetic analysis of haemophilia B in its Indian perspective
Determining the adequate number of internal quality control levels: the example of coagulation factor VIII assay
Thrombotic thrombocytopenic purpura associated with multiple myeloma
Coexistence of left-sided inferior vena cava, deep vein thrombosis of the upper and lower extremities and prothrombotic polymorphisms in a young patient: a case report
An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment
Occurrence of the JAK2 V617F mutation in the Budd–Chiari syndrome
Evaluation of urokinase plasminogen activator in urine from individuals with Quebec platelet disorder
Deep venous thrombosis associated with antiphospholipid antibodies following tuberculosis lymphadenitis in a predisposed patient
Interaction between thrombin mutant W215A/E217A and direct thrombin inhibitor
Low prevalence of the JAK2V617F in patients with ischemic stroke or cerebral venous thrombosis